This article is a correction to:
Bi-specific autoantigen-T cell engagers as targeted immunotherapy for autoreactive B cell depletion in autoimmune diseases
Luca Perico1†
Federica Casiraghi1†
Fabiane Sônego2
Marta Todeschini1Daniela Corna1
Domenico Cerullo1
Anna Pezzotta1Patricia Isnard-Petit2
Silvia Faravelli3
Federico Forneris3Kader Thiam2
Ariela Benigni1*‡
Giuseppe Remuzzi1‡- 1Department of Molecular Medicine, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy
- 2Preclinical Models & Services, genOway, Lyon, France
- 3The Armenise-Harvard Laboratory of Structural Biology, Department of Biology and Biotechnology, University of Pavia, Pavia, Italy
A Corrigendum on
Bi-specific autoantigen-T cell engagers as targeted immunotherapy for autoreactive B cell depletion in autoimmune diseases
By Perico L, Casiraghi F, Sônego F, Todeschini M, Corna D, Cerullo D, Pezzotta A, Isnard-Petit P, Faravelli S, Forneris F, Thiam K, Benigni A and Remuzzi G (2024) Front. Immunol. 15:1335998. doi: 10.3389/fimmu.2024.1335998
In the published article, there was an error. Typographical errors have been identified in the Methods section pertaining to the description of targeting vector construction for homologous recombination.
A correction has been made to Materials and methods, 4.3 Construction of targeting vectors for homologous recombination in embryonic stem cells. This sentence previously stated:
“The homology arms were isolated by cloning from C57BL/6N mouse genomic DNA. Three targeting vectors were generated targeting specifically Cd3γ, Cd3δ and Cd3ϵ extracellular domains genes in C57BL/6N mouse ES cells. For the Cd3γ targeting vector, the humanizing chimeric CD3γ cDNA was introduced into the murine exon 3 by DNA synthesis. A loxP-flanked puromycin resistance cassette was inserted in 3’ of the humanized cassette. For the Cd3δ targeting vector, the humanizing chimeric CD3δ cDNA was introduced into the murine exon 2 by DNA synthesis. An FRT-flanked hygromycin resistance cassette was inserted in 3’ of the humanized cassette. For the Cd3ϵ targeting vector, the humanizing chimeric CD3ϵ cDNA was introduced into the murine exon 2 by DNA synthesis. A lox2272-flanked neomycin resistance cassette was inserted in 3’ of the humanized cassette. The integrity of the targeting vectors was assessed by full sequencing.”
The corrected sentence appears below:
“The homology arms were isolated by cloning from C57BL/6N mouse genomic DNA. Three different targeting vectors were generated to humanize the three different genes, part of the Cd3 locus: a first vector composed of a CD3γ cDNA upstream of a lox2272-flanked neomycin cassette has been inserted in frame with Cd3γ exon 2; a second vector composed of a CD3δ cDNA upstream of an FRT-flanked hygromycin cassette has been inserted in frame with murine Cd3δ exon 2; a third vector composed of a CD3ϵ complete cDNA upstream of a loxP-flanked puromycin cassette has been inserted in frame with murine Cd3ϵ exon 3. All targeting were performed in cis. The insertion of the human sequences under the control of the mouse promoters and regularity regions prevents the production of the three endogenous mouse Cd3γ, Cd3δ and Cd3ϵ proteins. The integrity of the targeting vectors was assessed by full sequencing.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: autoimmune diseases, membranous nephropathy, anti-PLA2R antibodies, autoreactive B cell, targeted immunotherapies, bi-specific autoantigen-T cell engagers
Citation: Perico L, Casiraghi F, Sônego F, Todeschini M, Corna D, Cerullo D, Pezzotta A, Isnard-Petit P, Faravelli S, Forneris F, Thiam K, Benigni A and Remuzzi G (2025) Corrigendum: Bi-specific autoantigen-T cell engagers as targeted immunotherapy for autoreactive B cell depletion in autoimmune diseases. Front. Immunol. 15:1543066. doi: 10.3389/fimmu.2024.1543066
Received: 10 December 2024; Accepted: 17 December 2024;
Published: 09 January 2025.
Edited and Reviewed by:
Anisur Rahman, University College London, United KingdomCopyright © 2025 Perico, Casiraghi, Sônego, Todeschini, Corna, Cerullo, Pezzotta, Isnard-Petit, Faravelli, Forneris, Thiam, Benigni and Remuzzi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Ariela Benigni, YXJpZWxhLmJlbmlnbmlAbWFyaW9uZWdyaS5pdA==
†These authors have contributed equally to this work and share first authorship
‡These authors have contributed equally to this work and share last authorship